Kiniksa Pharmaceuticals chief accounting officer Michael R. Megna sells $3.42 million in common shares
KNSA•Kiniksa Pharmaceuticals Chief Accounting Officer Michael R. Megna sold 36,260 Class A ordinary shares on October 30, 2026, at prices ranging from $91.87 to $97.74 per share.
1. Share sale and options
Megna also exercised options for 19,895 Class A ordinary shares at exercise prices ranging from $10.76 to $17.76. After the transactions, he directly owned 12,697 Class A ordinary shares.
